COVID-19 news from experts at Columbia University Irving Medical Center. Visit our Coronavirus Resource Center for the latest COVID-19 information for CUIMC providers, staff, students, researchers and patients.
Search All News
A new study published in Nature offers reassuring data on the updated COVID vaccines.
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Brain development is normal in babies whose moms had mild COVID during pregnancy, a study by Columbia University researchers has found.
- January 11, 2021
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
- January 5, 2021
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
- December 31, 2020
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
- December 21, 2020
Front-line physicians, nurses, and staff at Columbia University Irving Medical Center have begun receiving the initial doses of the first COVID vaccines.
- December 18, 2020
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
- November 30, 2020
Columbia’s Evelyn Berger-Jenkins, MD, has co-authored new recommendations to help pediatricians address emotional and behavioral health issues in children during the COVID-19 pandemic.
- November 19, 2020
Columbia University COVID researchers are working to improve coronavirus testing, find new antivirals, and develop new ways to prevent transmission.